Corvention today announced the successful completion of the first case performed in the United States utilizing its proprietary KardiaPSI™ balloon catheter.

Corvention today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its KardiaPSI™ Balloon Catheter.